Inspection Record

The Shandex Sales Group Limited — Health Canada Inspection Findings

Health CanadaInspected 2026-03-10 5 findingsQuality unit oversightDeviation, CAPA, and investigationLaboratory and QC controlsComputer system validationOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The quality control department did not evaluate the results of the annual product quality review.

2Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

3Laboratory and QC controls

The validation and/or the documentation of test methods was inadequate.

4Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

5Other quality system

The written specifications were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2026-03-10. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

The Shandex Sales Group Limited findings history — including this company's other documents Health Canada documents, 2026 Go to Findings search